National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- G
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- PAR-25-081
- Posted
- Nov 12, 2024
- Response due
- Jan 7, 2027
- Archive date
- Feb 12, 2027
- CFDA / Assistance listing
- 93.393,93.394,93.395,93.399
- Award ceiling
- $499,999
- Total program funding
- $499,999
- Contact
- grantsinfo@nih.gov
- Source
- Grants.gov
Description
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.